In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Hikma Pharmaceuticals PLC Balance Sheet Statement - Assets

As of 31 Dec 2021, The total current assets of Hikma Pharmaceuticals PLC (LSE:HIK) was around $2,094,000,000 which consisted of $426,000,000 of Cash, $695,000,000 of Inventory and $876,000,000 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in USD

Cash
$426M
Current assets
$2.09B
Total assets
$4.37B

The latest balance sheet of Hikma Pharmaceuticals PLC also showed $1,146,000,000 of Property Plant Equipment and $285,000,000 of Good will. Also there were $607,000,000 of Intangible assets and $194,000,000 of Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $4,372,000,000.

Hikma Pharmaceuticals PLC Balance Sheet Statement - Liabilities

HIK's latest annual results shows the balance sheet has $262,000,000 of Accounts Payable. Also there were $48,000,000 of Short/Long term debt, $651,000,000 of Long term debt, $328,000,000 of Other Current liabilities and $1,016,000,000 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$262M
Current liabilities
$1.02B
Total liabilities
$1.91B

As per the 31 Dec 2021's annual report of Hikma Pharmaceuticals PLC, the total liabilities were $1,905,000,000.

HIK Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Hikma Pharmaceuticals PLC showed the total stock holder equity was $2,453,000,000 which consisted of $42,000,000 of Common stocks, $2,189,000,000 of Retained earnings and $-60,000,000 of Other stock holder equity.

HIK Balance Sheet Statement History

Following table shows the history of balance sheet for Hikma Pharmaceuticals PLC (HIK).

31 Dec 202131 Dec 202031 Dec 201931 Dec 2018
Cash426M323M442M276M
Net Receivables876M736M747M745M
Inventory695M757M568M528M
Total Current Assets2.09B1.92B1.85B1.67B
Property Plant Equipment1.15B1.07B962M870M
Good Will285M289M282M279M
Intangible Assets607M587M552M487M
Other Assets194M235M257M155M
Deferred Long Term Asset Charges183M221M243M125M
Total Assets4.37B4.13B3.93B3.5B
Accounts Payable262M279M286M263M
Short/Long Term Debt48M41M509M9M
Other Current Liabilities328M304M350M275M
Long Term Debt651M692M48M539M
Other Liabilities164M195M223M345M
Total Current Liabilities1.02B1.03B1.47B893M
Total Liabilities1.91B1.99B1.8B1.8B
Common Stock42M41M41M40M
Retained Earnings2.19B1.89B1.97B1.58B
Treasury Stock-60M-80M-179M-217M
Other Stockholder Equity-60M-80M-178M-216M
Total Stockholder Equity2.45B2.13B2.12B1.69B
Net Tangible Assets1.56B1.26B1.28B919M

Hikma Pharmaceuticals PLC (LSE:HIK) Balance Sheet Statement FAQ

1. How much Cash Hikma Pharmaceuticals PLC has on their balance sheet?

As of 31 Dec 2021, Hikma Pharmaceuticals PLC (LSE:HIK) has $426,000,000 of Cash.

2. What's the long term debt of Hikma Pharmaceuticals PLC?

As per the latest Balance sheet of Hikma Pharmaceuticals PLC (LSE:HIK), it has $651,000,000 of Long term debt.

3. How much share holder equity does Hikma Pharmaceuticals PLC has?

The Hikma Pharmaceuticals PLC (LSE:HIK)'s balance sheet shows that it has $2,453,000,000 of Total stock holder equity.